TheJobsMapTallac Therapeutics jobs and careers
Burlingame, CA, United States
About Tallac Therapeutics
Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.
Founded in 2018 by Ayman Kabakibi, Corey Goodman, Hong I. Wan and Sukumar Sakamuri.
- Founded
- 2018
- Employees
- 11 to 50
- Total funding
- $88.2M
- Headquarters
- Burlingame
Leadership
The top of Tallac Therapeutics's org chart, with how many people report into each leader.
Maja Zukic Bonacorsi
Principal Scientist
1 report
Curtis Hecht
Chief Business Officer
Mark Karbarz
Executive Director of Biologics Development, Head of CMC
Ons H.
Associate Director, Clinical Biomarkers
Emma S.
Senior Scientist
Jobs at Tallac Therapeutics
No open positions right now. Explore more companies on TheJobsMap.